Koji Inui
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Koji Inui has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
Hiroko Tsukamoto
Department of Developmental Medicine (Pediatrics), Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita City, Osaka 565-0871, Japan
4 shared publicationsShintaro Okada
Department of Developmental Medicine (Pediatrics), Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita City, Osaka 565-0871, Japan
4 shared publicationsMotohiro Akagi
Department of Developmental Medicine (Pediatrics), Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita City, Osaka 565-0871, Japan
3 shared publicationsTakashi Muramatsu
Department of Developmental Medicine (Pediatrics), Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita City, Osaka 565-0871, Japan
3 shared publicationsKatsumi Imai
2 shared publicationsNorio Sakai
Department of Developmental Medicine (Pediatrics), Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita City, Osaka 565-0871, Japan
2 shared publications
Latest Publications
- 1 January 2002
- No. 37
[Severe myoclonic epilepsy in infancy].
- 1 July 2001
- Published by Elsevier in Brain and Development
- Vol. 23 (4) , 212-215
Mutational analysis of MECP2 in Japanese patients with atypical Rett syndrome
- 1 July 2001
- Published by Elsevier in Brain and Development
- Vol. 23 (4) , 212-215
Mutational analysis of MECP2 in Japanese patients with atypical Rett syndrome
- 1 January 2000
- Published by Elsevier in Brain and Development
- Vol. 22 (1) , 47-49
A case of chronic infantile type of fucosidosis: clinical and magnetic resonance image findings
- 1 January 2000
- Published by Elsevier in Brain and Development
- Vol. 22 (1) , 47-49
A case of chronic infantile type of fucosidosis: clinical and magnetic resonance image findings
- Open Access
- 1 January 2000
- Published by Springer Nature in Journal of Human Genetics
- Vol. 45 (1) , 60-62
Mutation analysis of two Japanese patients with Fanconi-Bickel syndrome
Fanconi-Bickel syndrome (FBS), or glycogen storage disease type XI, is a rare autosomal recessive disorder characterized by hepatorenal glycogen accumulation, Fanconi nephropathy, and impaired utilization of glucose and galactose. Recently, this disease was elucidated to link mutations in the glucose transporter 2 (GLUT2) gene. Only three mutations in three FBS families have been reported. Therefore, it is important to elucidate mutations in the GLUT2 gene in FBS by answering the question of whether the syndrome is a single gene disease. In this report, we describe two patients in two unrelated families clinically diagnosed with FBS. No mutation in the entire protein coding region of the GLUT2 gene was detected in patient 1, which suggested that no mutation existed in the GLUT 2 gene, or that some mutations had affected the expression of the GLUT 2 gene. In patient 2, a novel homozygous nonsense mutation (W420X, Trp at codon 420 to stop codon) was detected. These results support the correlation between GLTU2 gene mutation and FBS syndrome. However, many patients must be analyzed to determine whether other genes are involved in FBS.
- 1 January 2000
- Published by Springer Nature in Journal of Human Genetics
- Vol. 45 (1) , 60-62
Open AccessMutation analysis of two Japanese patients with Fanconi-Bickel syndrome
Fanconi-Bickel syndrome (FBS), or glycogen storage disease type XI, is a rare autosomal recessive disorder characterized by hepatorenal glycogen accumulation, Fanconi nephropathy, and impaired utilization of glucose and galactose. Recently, this disease was elucidated to link mutations in the glucose transporter 2 (GLUT2) gene. Only three mutations in three FBS families have been reported. Therefore, it is important to elucidate mutations in the GLUT2 gene in FBS by answering the question of whether the syndrome is a single gene disease. In this report, we describe two patients in two unrelated families clinically diagnosed with FBS. No mutation in the entire protein coding region of the GLUT2 gene was detected in patient 1, which suggested that no mutation existed in the GLUT 2 gene, or that some mutations had affected the expression of the GLUT 2 gene. In patient 2, a novel homozygous nonsense mutation (W420X, Trp at codon 420 to stop codon) was detected. These results support the correlation between GLTU2 gene mutation and FBS syndrome. However, many patients must be analyzed to determine whether other genes are involved in FBS.
- 1 April 1999
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 22 (2) , 155-162
Molecular heterogeneity of Krabbe disease
Krabbe disease (globoid cell leukodystrophy) is an autosomal recessive neurodegenerative disorder that affects both the central and peripheral nervous system due to an enzymatic defect of galactocerebrosidase (GALC). Following its cloning, many mutations in the galactocerebrosidase gene have been reported, but the correlation between phenotype and genotype was not clear in many cases. In this study we further investigated the molecular defects in another 10 patients (6 Japanese and 4 non‐Japanese), using cultured skin fibroblasts, and found 10 mutations, of which 8 were novel, including a nonsense mutation (W647X) and 7 missense mutations (G43R, S52F, T262I, Y319C, W410G, R515H, T652R) in the coding region. Some phenotype‐specific mutations were found but the other mutations were private. Mutations reported so far have been distributed over the whole GALC gene and it is difficult to speculate on functional domains of the GALC protein and phenotypically specific regions.
- 1 April 1999
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 22 (2) , 155-162
Molecular heterogeneity of Krabbe disease
Krabbe disease (globoid cell leukodystrophy) is an autosomal recessive neurodegenerative disorder that affects both the central and peripheral nervous system due to an enzymatic defect of galactocerebrosidase (GALC). Following its cloning, many mutations in the galactocerebrosidase gene have been reported, but the correlation between phenotype and genotype was not clear in many cases. In this study we further investigated the molecular defects in another 10 patients (6 Japanese and 4 non‐Japanese), using cultured skin fibroblasts, and found 10 mutations, of which 8 were novel, including a nonsense mutation (W647X) and 7 missense mutations (G43R, S52F, T262I, Y319C, W410G, R515H, T652R) in the coding region. Some phenotype‐specific mutations were found but the other mutations were private. Mutations reported so far have been distributed over the whole GALC gene and it is difficult to speculate on functional domains of the GALC protein and phenotypically specific regions.
- 1 June 1994
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 3 (6) , 995-996
One base deletion in the cysteine-rich domain of the dystrophin gene in Duchenne muscular dystrophy patients
- 1 June 1994
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 3 (6) , 995-996
One base deletion in the cysteine-rich domain of the dystrophin gene in Duchenne muscular dystrophy patients